It is a fairly widely-held belief that more patient friendly options to receive biologics must be developed so that patients are more likely to comply with the dosage prescriptions. At the 16th Annual Drug Delivery Partnerships Conference, industry experts will share their first hand perspectives on the current landscape of biologic drug delivery from both pharmaceutical and technology companies and answer questions like:
- Do they foresee patient friendly delivery methods of biologics a rising priority for Pharma companies?
- Which technologies are the most promising in the area of biologic delivery?
What do you think?